AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Cleveland Clinic’s New AI Method Sharpens Target Discovery for Brain Disorders
Cleveland Clinic researchers have developed a new AI method aimed at refining drug target discovery for brain disorders. The work is notable because neuroscience remains one of the hardest areas for drug development, where biology is complex and clinical failures are common. If the approach improves target selection, it could help reduce one of the costliest sources of attrition in neurological drug pipelines.
St. Jude says AI helped identify IRS4 as a promising tumor target across multiple solid cancers
Researchers at St. Jude report that an AI-assisted approach identified IRS4 as a promising drug target in several solid tumors. The finding highlights how AI is increasingly being used not just to analyze known disease biology, but to surface cross-cancer targets with translational potential.
AI-assisted screening opens a new route for herbal drug discovery
Researchers say AI-powered phenotype-target coupled screening offers a new path for herbal drug discovery. The approach hints that AI could help modernize traditional medicine research by making it more systematic, testable, and compatible with contemporary discovery pipelines.
OpenAI’s GPT-Rosalind Shows How Foundation Models Are Entering Drug Discovery
OpenAI has reportedly introduced GPT-Rosalind, a model aimed at speeding drug discovery. The move suggests general-purpose AI labs are now targeting one of biotech’s most valuable and difficult problem sets, not just consumer software and productivity tools.
MIT Sloan Backs Research on How AI Is Changing Work and Healthcare Outcomes
MIT Sloan said its HSI Funds will support research into the relationship between AI, work, and healthcare outcomes. The project reflects growing interest in the downstream effects of AI adoption, not just whether the technology works technically.
A Digital Twin Model Connects Mental Health and Type 2 Diabetes in New Research
Researchers have used a “digital twin” approach to link mental health and type 2 diabetes, illustrating how AI models may help reveal connections across chronic conditions. The work highlights the promise of synthetic patient modeling while also raising questions about validation and clinical use.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.